research Bioactive Citrate-based Polyurethane Tissue Adhesive for Fast Sealing and Promoted Wound Healing
The new adhesive seals wounds quickly, works well in wet conditions, and helps with healing.
Search
for
Sort by
Research
990-1000 / 1000+ results research Alopecia areata clinical trial enrollment and retention outcome factors among underrepresented ethnic and racial groups: A cross-sectional study
Clinical trials for alopecia areata need better inclusion and retention of patients of color.
research Exploration of Therapeutic Ethno-Medicinal Plants used by Traditional Healers & Practitioners of Raichur District, Karnataka, India
Traditional healers in Raichur use 69 plants to treat various ailments, highlighting the need to preserve this knowledge.
research Role of Barever Natural Hair Inhibitor in Reducing Unwanted Body Hair Growth; As an Adjuvant Therapy with Waxing and with Normal Hair Removal Cream
Barever Natural Hair Inhibitor can help reduce unwanted body hair growth long-term when used with waxing or hair removal cream.
research Simultaneous Typing of Erythrocyte Acid Phosphatase, Adenylate Kinase and Adenosine Deaminase in Human Hair Root Sheaths
Hair root sheaths can be used to accurately analyze genetic markers.
research Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition
Applying certain vesicles from umbilical cord stem cells helps heal skin wounds in diabetic mice by reducing cell death and inflammation.
research Scientific Basis for the Therapeutic Uses of Semecarpus anacardium Linn. (Bhallataka): A Systematic Review
Semecarpus anacardium Linn. may have health benefits, but more research is needed to confirm its safety and effectiveness.
research Boundary-aware Multi-stage with Mobile U-Net for Hair Segmentation in Dermoscopic Images
The new method improves hair segmentation in skin images, helping detect skin cancer more accurately.
research 050 Evaluation of 3 month data for the use of erenumab for chronic migraine in Glasgow
Erenumab significantly reduced migraine days or severity in most patients after 3 months.